MUMBAI, India and VANCOUVER, BC, July 13, 2022 /PRNewswire/ Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven, global pharmaceutical company and SaNOtize Research and Development
Phase 3 trial in India met the key endpoints and demonstrated reduction of viral load of 94% in 24 hours and 99% in 48 hours. NONS was safe and well tolerated in COVID-19 patients. Glenmark
Glenmark Pharmaceuticals receives ANDA approval for Icatibant Injection, 30 mg/3 mL (10 mg/mL) Single-Dose Prefilled Syringe prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Glenmark Pharmaceuticals receives ANDA approval for Amphetamine Sulfate Tablets USP, 5 mg and 10 mg
News provided by
Share this article
MUMBAI, India, Jan. 28, 2021 /PRNewswire/ Glenmark Pharmaceuticals Limited (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Amphetamine Sulfate Tablets USP, 5 mg and 10 mg, the generic version of Evekeo®
1 Tablets, 5 mg and 10 mg, of Arbor Pharmaceuticals, LLC.
According to IQVIA
TM sales data for the 12 month period ending November 2020, the Evekeo® Tablets, 5 mg and 10 mg market
2 achieved annual sales of approximately $21.5 million .
Glenmark s current portfolio consists of 168 products authorized for distribution in the U.S. marketplace and 43 ANDA s pending approval with the U.S. FDA. In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.
Share this article
Share this article
Glenmark Pharmaceuticals receives ANDA final approval for Tadalafil Tablets, 2.5 mg, 5 mg, 10 mg and 20 mg;
and receives ANDA tentative approvals for Gabapentin Enacarbil Extended-Release Tablets, 300 mg and 600 mg
and Apremilast Tablets, 10 mg, 20 mg and 30 mg
MUMBAI, India, Dec. 31, 2020 /PRNewswire/ Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has received final approval by the United States Food & Drug Administration (U.S. FDA) for Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg and 20 mg, the generic version of Cialis®
1 Tablets, 2.5 mg, 5 mg, 10 mg and 20 mg, of Eli Lilly and Company.
According to IQVIA
™ sales data for the 12 month period ending November 2020, the Cialis® Tablets, 2.5 mg, 5 mg, 10 mg and 20 mg market